Efforts to reform federal drug pricing program 340B continue with new report, proposed CMS rule

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved patients by requiring pharmaceutical companies to offer prescription discounts to qualifying providers.

But after some providers were caught taking advantage of the program and shortchanging patients, state and federal lawmakers have spent years deliberating potential reforms.

This summer, federal officials are seeking public feedback on congressional legislation drafted by a workgroup that Virginia Democratic …